• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, February 4, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS

Should we bring back extinct species?

Bioengineer by Bioengineer
April 7, 2013
in NEWS
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
 
Twenty years after the release of Jurassic Park, the dream of bringing back the dinosaurs remains science fiction. But scientists predict that within 15 years they will be able to revive some more recently extinct species, such as the dodo or the passenger pigeon, raising the question of whether or not they should – just because they can.
 
In the April 5 issue of Science, Stanford law Professor Hank Greely identifies the ethical landmines of this new concept of de-extinction.
 
"I view this piece as the first framing of the issues," said Greely, director of the Stanford Center for Law and the Biosciences. "I don't think it's the end of the story, rather I think it's the start of a discussion about how we should deal with de-extinction."
 
In "What If Extinction Is Not Forever?" Greely lays out potential benefits of de-extinction, from creating new scientific knowledge to restoring lost ecosystems. But the biggest benefit, Greely believes, is the "wonder" factor.
 
"It would certainly be cool to see a living saber-toothed cat," Greely said. "'Wonder' may not seem like a substantive benefit, but a lot of science – such as the Mars rover – is done because of it."
 
Greely became interested in the ethics of de-extinction in 1999 when one of his students wrote a paper on the implications of bringing back wooly mammoths.
 
"He didn't have his science right – which wasn't his fault because approaches on how to do this have changed in the last 13 years – but it made me realize this was a really interesting topic," Greely said.
 
Scientists are currently working on three different approaches to restore lost plants and animals. In cloning, scientists use genetic material from the extinct species to create an exact modern copy. Selective breeding tries to give a closely-related modern species the characteristics of its extinct relative. With genetic engineering, the DNA of a modern species is edited until it closely matches the extinct species.
 
 All of these techniques would bring back only the physical animal or plant.
 
"If we bring the passenger pigeon back, there's no reason to believe it will act the same way as it did in 1850," said co-author Jacob Sherkow, a fellow at the Stanford Center for Law and the Biosciences. "Many traits are culturally learned. Migration patterns change when not taught from generation to generation."
 
Many newly revived species could cause unexpected problems if brought into the modern world. A reintroduced species could become a carrier for a deadly disease or an unintentional threat to a nearby ecosystem, Greely says.
 
"It's a little odd to consider these things 'alien' species because they were here before we were," he said. "But the 'here' they were in is very different than it is now. They could turn out to be pests in this new environment."
 
When asked whether government policies are keeping up with the new threat, Greely answers "no."
 
"But that's neither surprising nor particularly concerning," he said. "It will be a while before any revised species is going to be present and able to be released into the environment."
 
Greely and Sherkow recommend that the government leave de-extinction research to private companies and focus on drafting new regulations. Sherkow says the biggest legal and ethical challenge of de-extinction concerns our own long-lost ancestors.
 
"Bringing back a hominid raises the question, 'Is it a person?' If we bring back a mammoth or pigeon, there's a very good existing ethical and legal framework for how to treat research animals. We don't have very good ethical considerations of creating and keeping a person in a lab," said Sherkow. "That's a far cry from the type of de-extinction programs going on now, but it highlights the slippery slope problem that ethicists are famous for considering."

Story Source:

The above story is reprinted from materials provided by Stanford News Service- Thomas Sumner.

Tags: Extinct Species
Share12Tweet8Share2ShareShareShare2

Related Posts

World Cancer Day

Health Equity Report Card pilot project to help close the care gap highlighted on World Cancer Day

February 4, 2023
AC hum noise-based detection using HumTouch.

Tech that turns household surfaces into touch sensors is a touch closer to application

February 4, 2023

Preference for naturally talented over hard workers emerges in childhood, HKUST researchers find

February 4, 2023

Black South Africans report higher life satisfaction and are at less risk for depression post-migration, MU study finds

February 3, 2023
Please login to join discussion

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Health Equity Report Card pilot project to help close the care gap highlighted on World Cancer Day

Tech that turns household surfaces into touch sensors is a touch closer to application

Preference for naturally talented over hard workers emerges in childhood, HKUST researchers find

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In